Evogene Market Cap

Evogene has a market cap or net worth of 41.72 million as of July 11, 2025. Its market cap has decreased by -63.75% in one year.

Market Cap

41.72M

Enterprise Value

74.43M

Revenue

25.19M

Ranking

n/a

PE Ratio

n/a

Stock Price

447.80

Market Cap Chart

Since October 15, 2007, Evogene's market cap has decreased from 113.15M to 41.72M, a decrease of -63.13%. That is a compound annual growth rate of -5.47%.

Market Cap History

Date	Market Cap	% Change
Jul 10, 2025	41.72M	-11.89%
Dec 31, 2024	47.35M	-68.75%
Dec 31, 2023	151.55M	64.52%
Dec 29, 2022	92.12M	-58.37%
Dec 30, 2021	221.26M	-59.72%
Dec 31, 2020	549.28M	305.78%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 31, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Teva Pharmaceutical Industries	62.87B
Danel (Adir Yeoshua)	2.95B
Kamada	1.50B
Bait Bakfar	1.07B
SofWave Medical	848.94M
BrainsWay	806.16M
Novolog (Pharm-Up 1966)	720.29M
Ilex Medical	699.93M

Market Cap Rankings